website and are in the process of developing apps for mobile devices. The Journal is indexed everywhere and has, by Canadian standards, a relatively high impact factor. Financially, this Journal has had some good years and many challenging ones, with consistent advertising being somewhat elusive. Each year, we have provided the Journal free of charge to more than 10,000 Canadian physicians, serving as an important tool for knowledge translation for the CTS and, in addition, Pulsus has paid a percentage of revenues to the Society. We acknowledge and are appreciative of the CTS' consistent efforts to support the Journal and their commitment to pay for extra pages in the Journal to publish guidelines and special articles. Without this support, the timeline to publication of studies awaiting publication would have been extended significantly. Frankly, it also assured the Journal's survival during challenging times.
We don't need to tell you that the landscape for publishing has changed dramatically since the early 1990s. The recent Pharmaceutical Advertising Advisory Board-driven change to remove the requirement for printed prescribing information has had a significant impact on the Canadian medical publishing industry. At the same time, there is increased pressure from authors to have their research available open access immediately. We have, therefore, developed an option that will allow researchers to pay (per published page) to have their material published open access as quickly as possible following acceptance. It should be noted that this material will not be given priority over articles awaiting publication but rather will be published in addition to the regular material.
Our projection for the Journal in 2014 is currently very positive given the planned product launches. Eventually, however, we must all prepare for the day that advertising will no longer be sufficient to support the Journal all by itself and we will need to move to a hybrid model of industry/author support to thrive. The Canadian Journal of Infectious Diseases & Medical Microbiology is a fine example (having moved to this model three years ago) of how successful this model can be in securing financial stability.
The Canadian Respiratory Journal has weathered many storms and is here to stay -at least for another 20 years. And here's to all of us for making it happen!
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